Centerpoint Advisors’s Amgen AMGN Stock Holding History

Centerpoint Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$10K	Hold	28	–	–	﹤0.01%	331
2026 Q1	$10K	Hold	28	–	–	﹤0.01%	315
2025 Q4	$9K	Sell	28 -8	-22%	-$2.54K	﹤0.01%	323
2025 Q3	$10K	Sell	36 -77	-68%	-$22.3K	﹤0.01%	329
2025 Q2	$32K	Sell	113 -71	-39%	-$20.1K	0.01%	184
2025 Q1	$57K	Hold	184	–	–	0.02%	152
2024 Q4	$48K	Hold	184	–	–	0.02%	181
2024 Q3	$59K	Hold	184	–	–	0.02%	160
2024 Q2	$57K	Buy	+184	New	+$54.1K	0.02%	156
2021 Q3	–	Sell	-34	Closed	-$8K	–	292
2021 Q2	$8K	Buy	+34	New	+$8.36K	﹤0.01%	211
2021 Q1	–	Sell	-33	Closed	-$8K	–	267
2020 Q4	$8K	Hold	33	–	–	0.01%	176
2020 Q3	$8K	Hold	33	–	–	0.01%	152
2020 Q2	$8K	Hold	33	–	–	0.01%	165
2020 Q1	$7K	Hold	33	–	–	0.01%	158
2019 Q4	$8K	Hold	33	–	–	0.01%	175
2019 Q3	$6K	Hold	33	–	–	﹤0.01%	184
2019 Q2	$6K	Buy	+33	New	+$5.91K	﹤0.01%	178
2018 Q2	–	Sell	-41	Closed	-$7K	–	366
2018 Q1	$7K	Buy	+41	New	+$7.53K	0.01%	170

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Centerpoint Advisors's AMGN Position: Q2 2026 in Review

Centerpoint Advisors held its Amgen (AMGN) position steady in Q2 2026 at 28 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #331.

Centerpoint Advisors first reported a position in AMGN in Q1 2018 and has held it in 18 quarters since. The position peaked at $59K in Q3 2024. 3,156 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Centerpoint Advisors held 28 shares of Amgen worth $10K as of Q2 2026.
Centerpoint Advisors left its Amgen share count unchanged in Q2 2026.
Amgen made up ﹤0.01% of Centerpoint Advisors's portfolio in Q2 2026, its #331 holding.
Centerpoint Advisors first reported a position in Amgen in Q1 2018 and has held it in 18 quarters since.
Centerpoint Advisors's Amgen position peaked at $59K in Q3 2024.
3,156 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Centerpoint Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.